Clinical Trials Browser

Phase 2 × INDUSTRY × CIPN - Chemotherapy-Induced Peripheral Neuropathy × Clear all

NCT06538272 2025-04-03

Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel

Phase 2 Completed

CIPN - Chemotherapy-Induced Peripheral Neuropathy